A new study found that the Pfizer-BioNTech COVID-19 vaccine is highly effective against the Delta variant. The research showed that two doses of the vaccine provided strong protection against the variant, with an efficacy rate of 88%. This is reassuring news as the Delta variant continues to spread globally.
